Q2 Earnings Forecast for Oxbridge Re Issued By Maxim Group

Oxbridge Re Holdings Limited (NASDAQ:OXBRFree Report) – Analysts at Maxim Group issued their Q2 2026 EPS estimates for Oxbridge Re in a research report issued to clients and investors on Tuesday, June 16th. Maxim Group analyst A. Klee anticipates that the insurance provider will post earnings of $0.04 per share for the quarter. Maxim Group currently has a “Buy” rating and a $3.00 price objective on the stock. Maxim Group also issued estimates for Oxbridge Re’s Q3 2026 earnings at ($0.05) EPS, Q4 2026 earnings at ($0.05) EPS, FY2026 earnings at ($0.04) EPS, Q1 2027 earnings at ($0.06) EPS, Q2 2027 earnings at $0.04 EPS, Q3 2027 earnings at ($0.06) EPS, Q4 2027 earnings at ($0.06) EPS and FY2027 earnings at ($0.13) EPS.

Separately, Weiss Ratings downgraded Oxbridge Re from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, June 3rd. One investment analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $3.00.

Read Our Latest Research Report on Oxbridge Re

Oxbridge Re Price Performance

Oxbridge Re stock opened at $1.03 on Thursday. The company has a market capitalization of $8.34 million, a price-to-earnings ratio of -4.12 and a beta of 2.02. The company has a current ratio of 8.15, a quick ratio of 8.15 and a debt-to-equity ratio of 0.16. Oxbridge Re has a 12 month low of $0.66 and a 12 month high of $2.86. The stock’s 50 day moving average is $0.90 and its 200-day moving average is $1.06.

Oxbridge Re (NASDAQ:OXBRGet Free Report) last released its quarterly earnings results on Saturday, February 14th. The insurance provider reported $0.02 earnings per share for the quarter. Oxbridge Re had a negative net margin of 76.47% and a negative return on equity of 33.33%. The firm had revenue of $0.58 million for the quarter.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the business. International Assets Investment Management LLC raised its position in shares of Oxbridge Re by 61.2% in the first quarter. International Assets Investment Management LLC now owns 48,000 shares of the insurance provider’s stock valued at $54,000 after buying an additional 18,227 shares in the last quarter. J.W. Cole Advisors Inc. grew its position in Oxbridge Re by 106.1% during the fourth quarter. J.W. Cole Advisors Inc. now owns 68,000 shares of the insurance provider’s stock worth $90,000 after buying an additional 35,000 shares in the last quarter. Henrickson Nauta Wealth Advisors Inc. increased its stake in Oxbridge Re by 100.0% during the 4th quarter. Henrickson Nauta Wealth Advisors Inc. now owns 137,400 shares of the insurance provider’s stock worth $185,000 after acquiring an additional 68,700 shares during the period. Finally, Virtu Financial LLC acquired a new position in Oxbridge Re in the 3rd quarter valued at $32,000. 5.64% of the stock is owned by institutional investors.

Oxbridge Re News Summary

Here are the key news stories impacting Oxbridge Re this week:

  • Positive Sentiment: SurancePlus reported annualized returns of 29.3% and 43.4% on its tokenized reinsurance offerings, topping the original target returns and reinforcing the case for the company’s RWA platform. Article Title
  • Positive Sentiment: Maxim Group reiterated a Buy rating and $3.00 price target on Oxbridge Re while publishing multiple earnings estimates, which can support the stock by signaling analyst optimism.
  • Neutral Sentiment: Maxim’s latest forecasts still call for Oxbridge Re to post losses in several quarters and a full-year loss in FY2026 and FY2027, indicating the business remains unprofitable despite the bullish rating.

About Oxbridge Re

(Get Free Report)

Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.

The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.

Read More

Earnings History and Estimates for Oxbridge Re (NASDAQ:OXBR)

Receive News & Ratings for Oxbridge Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxbridge Re and related companies with MarketBeat.com's FREE daily email newsletter.